Search This Blog

Thursday, September 6, 2018

Intuitive Surgical submits robotic-assisted platform to FDA premarket


Intuitive Surgical announced it has submitted a premarket notification to the FDA for the company’s new flexible robotic-assisted, catheter-based platform, designed to navigate through very small lung airways to reach peripheral nodules for biopsies. Lung cancer is the world’s leading cause of cancer deaths. The majority of suspicious lesions found in the lung are small and difficult to access, which can make obtaining a diagnosis challenging.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.